These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1445929)

  • 1. Inhibition of platelet adhesion and thrombus formation on a collagen-coated surface by novel carbamoylpiperidine antiplatelet agents.
    Alevriadou BR; McIntire LV; Lasslo A
    Biochim Biophys Acta; 1992 Nov; 1137(3):279-86. PubMed ID: 1445929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mural thrombus formation by novel nipecotoylpiperazine antiplatelet agents.
    Owens CK; McIntire LV; Lasslo A
    Biochim Biophys Acta; 1990 May; 1052(3):351-9. PubMed ID: 2354206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass.
    Folie BJ; McIntire LV; Lasslo A
    Blood; 1988 Oct; 72(4):1393-400. PubMed ID: 3167213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombus formation in vivo by novel antiplatelet agent.
    Marzec UM; Kelly AB; Hanson SR; Lasslo A; Harker LA
    Arteriosclerosis; 1990; 10(3):367-71. PubMed ID: 2140503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
    Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
    Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol inhibition of thrombus formation on collagen-coated glass.
    Owens CK; McIntire LV; Lasslo A
    Thromb Haemost; 1990 Jun; 63(3):510-6. PubMed ID: 2402753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow.
    Folie BJ; McIntire LV
    Biophys J; 1989 Dec; 56(6):1121-41. PubMed ID: 2611327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
    J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.
    Bossavy JP; Sakariassen KS; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2269-75. PubMed ID: 10479672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability.
    Dillingham EO; Lasslo A; Gollamudi R; Bond SE; Carter-Burks G
    Res Commun Chem Pathol Pharmacol; 1990 Feb; 67(2):179-99. PubMed ID: 2333408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.
    Gir S; Reavis R; Turitto VT; Gollamudi R
    Biotechnol Appl Biochem; 1996 Feb; 23(1):63-6. PubMed ID: 8867897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and stability of thrombi in flowing citrated blood: assessment of platelet-surface interactions with computer-assisted morphometry.
    Sakariassen KS; Kuhn H; Muggli R; Baumgartner HR
    Thromb Haemost; 1988 Dec; 60(3):392-8. PubMed ID: 3238645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces.
    Maalej N; Albrecht R; Loscalzo J; Folts JD
    J Am Coll Cardiol; 1999 Apr; 33(5):1408-14. PubMed ID: 10193746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
    Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
    Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.